Design Variation of a Dual-Antigen Liposomal Vaccine Carrier System

Area of Science:

• Biotechnology
• Vaccine Development
• Nanotechnology

Background:

• Liposomal carriers are crucial for vaccine delivery.
• Developing effective dual-antigen vaccines requires precise control over carrier formulation.
• Pneumococcal disease necessitates advanced vaccine delivery systems.

Purpose of the Study:

• To characterize and compare dual-antigen liposomal carriers for vaccine delivery.
• To investigate the impact of formulation variables on encapsulation and surface localization.
• To optimize liposomal constructs for pneumococcal vaccination.

Main Methods:

• Formulation of liposomal carriers with altered base components.
• Encapsulation of polysaccharides and surface localization of proteins.
• Characterization of liposomal size, zeta potential, encapsulation efficiency, and protein localization.

Main Results:

• Liposomal constructs varied based on protein surface localization methods (metal vs. biological affinity).
• Successful constructs ranged from 50-600 nm in size with zeta potentials of -4 to -41 mV.
• Achieved over 60% polysaccharide encapsulation and 60% protein surface localization in optimal formulations.

Conclusions:

• Multiple liposomal formulations can support vaccination studies.
• Formulation selection depends on target antigens and regulatory requirements.
• Optimized liposomal carriers show promise for effective pneumococcal vaccines.